FDA Lifts Partial Clinical Hold on Lorigerlimab for Gynecologic Cancer | CancerNetwork

References. FDA removes partial clinical hold on MacroGenics’ LINNET study. News release. MacroGenics, Inc. April 8, 2026. Accessed April 9, …